News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,832 Results
Type
Article (88208)
Company Profile (823)
Press Release (784780)
Multimedia
Podcasts (208)
Webinars (32)
Section
Business (233356)
Career Advice (4152)
Deals (39899)
Drug Delivery (158)
Drug Development (91484)
Employer Resources (205)
FDA (18446)
Job Trends (17442)
News (398153)
Policy (39998)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (166)
Alliances (56982)
ALS (193)
Alzheimer's disease (1829)
Antibody-drug conjugate (ADC) (382)
Approvals (18647)
Artificial intelligence (689)
Autoimmune disease (207)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (70)
Breast cancer (700)
Cancer (5382)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (879)
Cervical cancer (41)
Clinical research (77476)
Collaboration (1977)
Company closure (6)
Compensation (1257)
Complete response letters (84)
COVID-19 (3005)
CRISPR (110)
C-suite (978)
Cystic fibrosis (157)
Data (6750)
Decentralized trials (2)
Denatured (77)
Depression (166)
Diabetes (556)
Diagnostics (7336)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (335)
Drug pricing (231)
Drug shortages (36)
Duchenne muscular dystrophy (262)
Earnings (100830)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135961)
Executive appointments (1076)
FDA (21837)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1660)
Gene editing (234)
Generative AI (71)
Gene therapy (725)
GLP-1 (1172)
Government (5486)
Grass and pollen (8)
Guidances (389)
Healthcare (20985)
HIV (76)
Huntington's disease (56)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (77)
Indications (136)
Infectious disease (3327)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (268)
Interviews (817)
IPO (17972)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (22)
Lung cancer (720)
Lymphoma (398)
Machine learning (49)
Management (66)
Manufacturing (935)
MASH (186)
Medical device (15100)
Medtech (15168)
Mergers & acquisitions (23055)
Metabolic disorders (1494)
mRNA (202)
Multiple sclerosis (180)
NASH (23)
Neurodegenerative disease (392)
Neuropsychiatric disorders (110)
Neuroscience (3270)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (732)
Opinion (350)
Ovarian cancer (177)
Pain (236)
Pancreatic cancer (254)
Parkinson's disease (323)
Partnered (39)
Patents (551)
Patient recruitment (561)
Peanut (65)
People (67197)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23936)
Phase 2 (33619)
Phase 3 (25327)
Pipeline (6254)
Policy (360)
Postmarket research (3554)
Preclinical (10732)
Press Release (72)
Prostate cancer (274)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1030)
Real estate (7445)
Recruiting (81)
Regulatory (29393)
Reports (69)
Research institute (2747)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (91)
Schizophrenia (166)
Series A (280)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (101)
The Weekly (129)
Vaccines (1195)
Venture capital (103)
Weight loss (498)
Women's health (107)
Worklife (23)
Date
Today (58)
Last 7 days (761)
Last 30 days (3059)
Last 365 days (32748)
2026 (6148)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (356)
Arkansas (15)
Asia (51719)
Australia (9086)
California (12297)
Canada (3499)
China (1244)
Colorado (519)
Connecticut (537)
Delaware (365)
Europe (119033)
Florida (1825)
Georgia (398)
Hawaii (4)
Idaho (68)
Illinois (1027)
India (82)
Indiana (576)
Iowa (24)
Japan (473)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1524)
Massachusetts (9032)
Michigan (381)
Minnesota (695)
Mississippi (7)
Missouri (146)
Montana (37)
Nebraska (30)
Nevada (136)
New Hampshire (88)
New Jersey (3310)
New Mexico (33)
New York (3238)
North Carolina (1691)
North Dakota (10)
Northern California (5954)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2449)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (71)
South Dakota (1)
Southern California (4768)
Tennessee (194)
Texas (1939)
United States (44245)
Utah (370)
Vermont (1)
Virginia (310)
Washington D.C. (88)
Washington State (1017)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,832 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Complete response letters
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did not flag problems with the drug’s efficacy or safety.
March 9, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Vertex Terminates 20 in Reorganization Push
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
March 9, 2026
·
32 min read
·
BioSpace Editorial Staff
Press Releases
Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-girdle Muscular Dystrophy
March 9, 2026
·
5 min read
Press Releases
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deleted Solid Tumors, and Provides MTAP and CDKN2A Pipeline Update
March 9, 2026
·
7 min read
Press Releases
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization
March 9, 2026
·
19 min read
Press Releases
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)
March 9, 2026
·
13 min read
Press Releases
European Commission approves AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer (mHSPC)
March 9, 2026
·
10 min read
Press Releases
HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China
March 9, 2026
·
6 min read
Press Releases
Naobios and SGS Partner to Manufacture Respiratory Syncytial Virus (RSV) Challenge Agent
March 9, 2026
·
2 min read
Press Releases
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions
March 9, 2026
·
9 min read
1 of 87,384
Next
